Literature DB >> 8625330

Clinical, toxicological and pharmacological aspects of gemcitabine.

H J Guchelaar1, D J Richel, A van Knapen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8625330     DOI： 10.1016/s0305-7372(96)90014-6

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  12 in total

Review 1.  Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.

Authors:  S Noble; K L Goa
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer.

Authors:  Lin-run Wang; Jian Liu; Ming-zhu Huang; Nong Xu
Journal:  J Zhejiang Univ Sci B       Date:  2007-05       Impact factor: 3.066

3.  Editorial for Cancer Virtual Issue.

Authors:  Benjamin E Blass
Journal:  ACS Med Chem Lett       Date:  2017-12-14       Impact factor: 4.345

4.  Combined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency.

Authors:  Nozomu Tanji; Tetsuya Fukumoto; Noriyoshi Miura; Yutaka Yanagihara; Akitomi Shirato; Koji Azuma; Yuki Miyauchi; Tadahiko Kikugawa; Kenji Shimamoto; Masayoshi Yokoyama
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

5.  Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.

Authors:  Steven R Alberts; Joel M Reid; Bruce W Morlan; Gist H Farr; John K Camoriano; David B Johnson; James R Enger; Thomas E Seay; George P Kim
Journal:  Am J Clin Oncol       Date:  2012-10       Impact factor: 2.339

6.  Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer.

Authors:  Lin-Run Wang; Ming-Zhu Huang; Nong Xu; Jian-Zhong Shentu; Jian Liu; Jie Cai
Journal:  J Zhejiang Univ Sci B       Date:  2005-05       Impact factor: 3.066

7.  Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.

Authors:  Doaa Ali Sharaf El Deen; Eman Abd Elkareem Toson; Shawky Mahmoud El Morsy
Journal:  Med Oncol       Date:  2012-06-08       Impact factor: 3.064

8.  Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer.

Authors:  Yang Chen; Yiqi DU; Ping Li; Fei Wu; Yan Fu; Zhaoshen Li; Yongzhang Luo
Journal:  Mol Clin Oncol       Date:  2014-03-27

9.  Clinical Targeting of Altered Metabolism in High-Grade Glioma.

Authors:  Andrew J Scott; Costas A Lyssiotis; Daniel R Wahl
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

10.  Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.

Authors:  V Grégoire; M Beauduin; J F Rosier; B De Coster; M Bruniaux; M Octave-Prignot; P Scalliet
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.